Physitrack PLC — Transactions under Share Buy-back Programme
14 september, 08:30
Physitrack PLC ("Physitrack" or the "Company") announces that, pursuant to the share buy-back programme announced on 21 July 2026, the Company has purchased its own ordinary shares on Nasdaq First North Growth Market Stockholm during the week of 7 September 2026 to 11 September 2026, as set out below.
Summary of transactions
Period | Total shares repurchased during the week | Volume-weighted average price paid (SEK) | Total consideration paid (SEK) | Total shares held by the Company (treasury) following these transactions | Total outstanding shares in the Company | Treasury holding as % of issued share capital |
7 September 2026 - 11 September 2026 | 6,442 | SEK 8.4780 | SEK 54,615.10 | 33,033 | 16,260,766 | 0.2031% |
Individual transactions
Date | Quantity | Average price (SEK) |
2026-09-07 | 1,750 | 8.6743 |
2026-09-08 | 1,500 | 8.4733 |
2026-09-09 | 692 | 8.3600 |
2026-09-10 | 1,500 | 8.4000 |
2026-09-11 | 1,000 | 8.3400 |
The share buy-back programme is conducted within the safe harbour of Article 5 of the Market Abuse Regulation (EU) No 596/2014 ("MAR") and Commission Delegated Regulation (EU) 2016/1052, for the purpose of meeting the Company's obligations under its employee share plans. The programme is executed by Pareto Securities on a non-discretionary basis on Nasdaq First North Growth Market Stockholm.
Notification details
1. Issuer | Physitrack PLC, LEI 213800PC4QYNWHPCP774 |
2. Instrument/ISIN | Ordinary shares / GB00BYX22590 |
3. Trading venue | Nasdaq First North Growth Market Stockholm (PTRK) |
4. Currency | SEK |
5. Purpose of buy-back | To meet the Company's obligations under its employee share plans (a permitted purpose under Article 5(2) of MAR) |
6. Executing broker | Pareto Securities (non-discretionary mandate) |
This information is disclosed pursuant to Article 5 of MAR and Commission Delegated Regulation (EU) 2016/1052.
About Physitrack
Physitrack plc (Nasdaq First North: PTRK), d/b/a Physitrack Group, is a global digital health and wellness SaaS delivering personalized, scalable remote care through its Physitrack and Champion Health platforms.
Physitrack enables healthcare providers to deliver and manage app-guided physical and occupational rehabilitation with measurable patient outcomes and built-in billing and reimbursement support, while Champion Health provides businesses with mental, physical, and financial wellbeing solutions to support workforce health and productivity.
Physitrack Group’s solutions seamlessly integrate with existing systems, including EMR/EHR/PMS connectivity, and are trusted by more than 80,000 providers and organizations across 180+ countries. For more information, visit www.physitrackgroup.com and follow us on LinkedIn and X.
Enquiries regarding this announcement should be addressed to:
Corporate Contact:
Henrik Molin, CEO and co-founder, Physitrack
ir@physitrack.com
media@physitrack.com
Investor and Media Contact:
Investor Relations
Jonathan@harbor-access.com
Tel +1 475 477 9401
Ämnen i artikeln
Physitrack PLC — Transactions under Share Buy-back Programme
14 september, 08:30
Physitrack PLC ("Physitrack" or the "Company") announces that, pursuant to the share buy-back programme announced on 21 July 2026, the Company has purchased its own ordinary shares on Nasdaq First North Growth Market Stockholm during the week of 7 September 2026 to 11 September 2026, as set out below.
Summary of transactions
Period | Total shares repurchased during the week | Volume-weighted average price paid (SEK) | Total consideration paid (SEK) | Total shares held by the Company (treasury) following these transactions | Total outstanding shares in the Company | Treasury holding as % of issued share capital |
7 September 2026 - 11 September 2026 | 6,442 | SEK 8.4780 | SEK 54,615.10 | 33,033 | 16,260,766 | 0.2031% |
Individual transactions
Date | Quantity | Average price (SEK) |
2026-09-07 | 1,750 | 8.6743 |
2026-09-08 | 1,500 | 8.4733 |
2026-09-09 | 692 | 8.3600 |
2026-09-10 | 1,500 | 8.4000 |
2026-09-11 | 1,000 | 8.3400 |
The share buy-back programme is conducted within the safe harbour of Article 5 of the Market Abuse Regulation (EU) No 596/2014 ("MAR") and Commission Delegated Regulation (EU) 2016/1052, for the purpose of meeting the Company's obligations under its employee share plans. The programme is executed by Pareto Securities on a non-discretionary basis on Nasdaq First North Growth Market Stockholm.
Notification details
1. Issuer | Physitrack PLC, LEI 213800PC4QYNWHPCP774 |
2. Instrument/ISIN | Ordinary shares / GB00BYX22590 |
3. Trading venue | Nasdaq First North Growth Market Stockholm (PTRK) |
4. Currency | SEK |
5. Purpose of buy-back | To meet the Company's obligations under its employee share plans (a permitted purpose under Article 5(2) of MAR) |
6. Executing broker | Pareto Securities (non-discretionary mandate) |
This information is disclosed pursuant to Article 5 of MAR and Commission Delegated Regulation (EU) 2016/1052.
About Physitrack
Physitrack plc (Nasdaq First North: PTRK), d/b/a Physitrack Group, is a global digital health and wellness SaaS delivering personalized, scalable remote care through its Physitrack and Champion Health platforms.
Physitrack enables healthcare providers to deliver and manage app-guided physical and occupational rehabilitation with measurable patient outcomes and built-in billing and reimbursement support, while Champion Health provides businesses with mental, physical, and financial wellbeing solutions to support workforce health and productivity.
Physitrack Group’s solutions seamlessly integrate with existing systems, including EMR/EHR/PMS connectivity, and are trusted by more than 80,000 providers and organizations across 180+ countries. For more information, visit www.physitrackgroup.com and follow us on LinkedIn and X.
Enquiries regarding this announcement should be addressed to:
Corporate Contact:
Henrik Molin, CEO and co-founder, Physitrack
ir@physitrack.com
media@physitrack.com
Investor and Media Contact:
Investor Relations
Jonathan@harbor-access.com
Tel +1 475 477 9401
Ämnen i artikeln
Analys
H&M:s tredje kvartal
25 september, 07:48
H&M-rapport splittrar analytikerna
Här är morgonens aktierekar.
Fastighetsaktier
Världens börser
24 september, 09:39
Styrräntan lämnas oförändrad
Flera höjningar väntas
Analys
H&M:s tredje kvartal
25 september, 07:48
H&M-rapport splittrar analytikerna
Här är morgonens aktierekar.
Fastighetsaktier
Världens börser
24 september, 09:39
Styrräntan lämnas oförändrad
Flera höjningar väntas
Marknadsöversikt
1 DAG %
Senast
1 mån
